Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model (Q36688749)

15 August 2017

1 reference

title

Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model (English)

1 reference

15 August 2017

0 references

2

Sally A Frautschy

1 reference

15 August 2017

Greg M Cole

1

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

18

1 reference

15 August 2017

249-259

1 reference

15 August 2017

3

1 reference

Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival

15 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Drebrin A is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Neuron numbers and dendritic extent in normal aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Microtubular reorganization and dendritic growth response in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: a two-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Dendrite and dendritic spine alterations in Alzheimer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Dendritic Spine "Dysgenesis" and Mental Retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Rho proteins, mental retardation and the cellular basis of cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

From superior adaptation and function to brain dysfunction--the neglect of epigenetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Transthyretin sequesters amyloid beta protein and prevents amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Alzheimer's disease: genotypes, phenotypes, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Regulation of NMDA receptor trafficking by amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Docosahexaenoic acid affects cell signaling by altering lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010600601800307

10.1177/026010600601800307

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17180870